Loading clinical trials...
Loading clinical trials...
A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease
Conditions
Interventions
Methoxsalen
Extracorporeal Photopheresis
Locations
31
United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
University of Florida
Gainesville, Florida, United States
Rush Presbyterian - St. Lukes Medical Center
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Tufts New England Medical Center
Boston, Massachusetts, United States
Brigham and Womens
Boston, Massachusetts, United States
Start Date
June 1, 2002
Completion Date
March 1, 2004
Last Updated
August 16, 2017
NCT07070674
NCT00001529
NCT06910969
NCT06660355
NCT07166848
NCT06294691
Lead Sponsor
Mallinckrodt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions